EID Parry (India) Ltd

₹ 507 4.16%
24 Jun - close price
About

EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]

Key Points

Business Segments
Sugar: The Co has been manufacturing sugar for more than two centuries and has expertise to manufacture sugar to critical specifications addressing specific customized needs.
Nutraceuticals: The Co creates science-based formulations of nutraceuticals supplements, functional foods, general nutrition, functional cosmetic ingredients and pharmaceutical formulations.
Sanitizers: Handkleen & Sterisafe are hand sanitization products introduced by the Co. [1]

Revenue Split (FY21)
Nutrient and allied business : 66%
Sugar: 20%
Crop protection: 11%
Other: 3 % [2]

  • Market Cap 8,996 Cr.
  • Current Price 507
  • High / Low 576 / 377
  • Stock P/E 9.86
  • Book Value 300
  • Dividend Yield 2.17 %
  • ROCE 37.0 %
  • ROE 18.4 %
  • Face Value 1.00

Pros

Cons

  • The company has delivered a poor sales growth of 10.33% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Sugar Industry: Sugar

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
3,126 5,675 4,082 4,245 4,142 5,836 4,701 3,877 4,354 6,978 6,528 5,667
2,966 5,017 3,605 3,622 3,712 4,961 4,136 3,607 3,920 6,233 5,915 5,050
Operating Profit 160 658 477 623 431 876 565 270 434 746 612 618
OPM % 5% 12% 12% 15% 10% 15% 12% 7% 10% 11% 9% 11%
27 23 32 16 18 15 -104 38 59 26 30 89
Interest 129 115 90 96 89 59 48 40 34 42 38 38
Depreciation 69 81 82 87 84 84 83 81 81 82 84 88
Profit before tax -11 484 337 456 276 748 330 186 379 648 521 581
Tax % 72% 21% 22% 45% 53% 25% 26% 67% 26% 27% 24% 26%
Net Profit -28 182 157 157 29 318 107 -6 133 244 228 303
EPS in Rs -1.57 10.26 8.86 8.88 1.66 17.96 6.02 -0.36 7.49 13.75 12.85 17.05

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
9,359 12,491 11,383 12,114 13,952 15,358 14,391 15,373 16,556 17,129 18,587 23,528
8,304 11,290 10,356 11,212 12,938 14,517 12,965 14,068 15,105 15,242 16,467 21,115
Operating Profit 1,056 1,202 1,027 902 1,014 841 1,426 1,305 1,450 1,887 2,121 2,413
OPM % 11% 10% 9% 7% 7% 5% 10% 8% 9% 11% 11% 10%
151 75 95 105 105 179 159 150 83 129 -14 203
Interest 209 294 388 465 420 451 417 336 425 430 236 152
Depreciation 174 190 215 226 244 250 248 251 272 319 332 334
Profit before tax 823 793 519 315 455 319 920 868 837 1,266 1,539 2,130
Tax % 33% 34% 30% 31% 39% 45% 23% 40% 48% 30% 35% 26%
Net Profit 312 313 207 78 117 35 521 256 153 468 447 907
EPS in Rs 18.03 18.01 11.77 4.44 6.64 1.96 29.61 14.45 8.67 26.43 25.26 51.12
Dividend Payout % 11% 22% 74% 62% 89% -0% 14% 21% 35% -0% -0% 22%
Compounded Sales Growth
10 Years: 7%
5 Years: 10%
3 Years: 12%
TTM: 27%
Compounded Profit Growth
10 Years: 11%
5 Years: 12%
3 Years: 79%
TTM: 91%
Stock Price CAGR
10 Years: 11%
5 Years: 10%
3 Years: 45%
1 Year: 12%
Return on Equity
10 Years: 11%
5 Years: 13%
3 Years: 15%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
17 17 18 18 18 18 18 18 18 18 18 18
Reserves 2,224 2,406 2,415 2,399 2,209 2,370 2,733 2,952 3,110 3,502 4,565 5,308
3,173 4,583 5,199 4,288 4,823 5,144 3,923 4,470 5,125 4,347 1,229 1,259
3,163 4,091 4,802 4,954 5,849 6,600 6,691 7,088 7,649 7,069 7,444 9,358
Total Liabilities 8,577 11,097 12,433 11,659 12,899 14,131 13,364 14,528 15,901 14,936 13,257 15,943
2,582 3,108 3,851 3,788 3,476 3,343 3,297 3,197 3,077 3,858 3,583 3,785
CWIP 343 605 489 163 75 77 39 54 203 85 206 139
Investments 183 156 180 358 369 688 569 430 418 413 453 563
5,468 7,229 7,914 7,350 8,979 10,022 9,459 10,847 12,203 10,579 9,014 11,456
Total Assets 8,577 11,097 12,433 11,659 12,899 14,131 13,364 14,528 15,901 14,936 13,257 15,943

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
301 370 838 1,591 222 437 1,969 259 -52 1,986 4,771 2,278
46 -979 -956 -260 -307 -192 -148 13 -357 -282 -548 -1,733
-417 648 -503 -1,263 -142 -221 -1,842 42 34 -1,769 -3,598 -499
Net Cash Flow -70 39 -621 68 -227 23 -21 314 -375 -65 625 46

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 15 36 65 52 45 49 47 43 46 45 17 9
Inventory Days 117 96 118 123 138 124 127 134 175 131 112 111
Days Payable 93 58 -0 74 74 131 150 83 148 96 65 104
Cash Conversion Cycle 39 73 183 101 109 42 24 94 73 80 64 16
Working Capital Days 83 85 108 73 84 88 87 90 115 104 55 41
ROCE % 20% 18% 12% 11% 13% 10% 19% 18% 16% 21% 27% 37%

Shareholding Pattern

Numbers in percentages

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
44.77 44.77 44.77 44.77 44.77 44.77 44.75 44.74 44.74 44.68 44.66 44.64
6.28 6.01 6.09 6.02 5.98 7.93 9.06 8.90 8.28 7.81 8.21 8.76
4.61 3.93 1.59 2.72 2.87 1.99 1.94 2.37 3.89 4.40 4.10 4.26
44.33 45.29 47.55 46.49 46.38 45.31 44.25 43.98 43.09 43.11 43.04 42.34

Documents